Literature DB >> 23722587

Current status and future perspectives of prosthetic valve selection for aortic valve replacement.

Hiroshi Furukawa1, Kazuo Tanemoto.   

Abstract

Aortic valve abnormality is the most frequent form of valvular heart disease. Notably, aortic stenosis in the elderly population has been increasingly common. Aortic valve replacement (AVR) using prosthetic valve has been still believed as a gold standard surgical intervention for various types of diseased aortic valve. The numerous reports and studies evaluating the clinical outcomes and durability of prosthesis were revealed, however, prosthesis selection for AVR is still debated. In twenty-first century, paradigm shift of prosthesis preference might be emerged from mechanical valves to bioprosthesis due to the development of the technology. Moreover, transcatheter aortic valve implantation accelerated among the worldwide trends. It could be developed having the potential to reduce the mortality and morbidity associated with high-risk traditional AVR. After the current guidelines for the management of patients with valvular heart disease, we should consider the valve choice in various patients' profile setting. This review summarizes the current status of prosthesis selection and future perspectives of ideal aortic valve intervention, including minimal invasive care.

Entities:  

Mesh:

Year:  2013        PMID: 23722587     DOI: 10.1007/s11748-013-0262-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  53 in total

1.  Sutureless aortic valve replacement with the Trilogy Aortic Valve System: multicenter experience.

Authors:  Ingo Breitenbach; Gerhard Wimmer-Greinecker; Leo A Bockeria; Jerzy Sadowski; Christoph Schmitz; Boguslaw Kapelak; Krzysztof Bartus; Ravil Muratov; Wolfgang Harringer
Journal:  J Thorac Cardiovasc Surg       Date:  2010-08-02       Impact factor: 5.209

2.  Small aortic annulus: the hydrodynamic performances of 5 commercially available tissue valves.

Authors:  Gino Gerosa; Vincenzo Tarzia; Giulio Rizzoli; Tomaso Bottio
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

3.  Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve Revalving system.

Authors:  Peter Wenaweser; Lutz Buellesfeld; Ulrich Gerckens; Eberhard Grube
Journal:  Catheter Cardiovasc Interv       Date:  2007-11-01       Impact factor: 2.692

4.  Perceval S aortic valve implantation in mini-invasive surgery: the simple sutureless solution.

Authors:  Giuseppe Santarpino; Steffen Pfeiffer; Giovanni Concistrè; Theodor Fischlein
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-05-22

5.  Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years.

Authors:  Charles A Yankah; Miralem Pasic; Michele Musci; Julia Stein; Christine Detschades; Henryk Siniawski; Roland Hetzer
Journal:  J Thorac Cardiovasc Surg       Date:  2008-07-14       Impact factor: 5.209

6.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

7.  Long-term clinical and echocardiographic follow-up of the Freestyle stentless aortic bioprosthesis.

Authors:  Siamak Mohammadi; Vincent Tchana-Sato; Dimitri Kalavrouziotis; Pierre Voisine; Daniel Doyle; Richard Baillot; Sandro Sponga; Jacques Metras; Jean Perron; François Dagenais
Journal:  Circulation       Date:  2012-09-11       Impact factor: 29.690

8.  Transcatheter aortic valve implantation in dialysis patients.

Authors:  Simon Rau; Matthias Wessely; Philipp Lange; Christian Kupatt; Gerhard Steinbeck; Michael Fischereder; Ulf Schönermarck
Journal:  Nephron Clin Pract       Date:  2012-02-22

9.  Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes.

Authors:  Willem Flameng; Marie-Christine Herregods; Hadewich Hermans; Gerry Van der Mieren; Monique Vercalsteren; Gert Poortmans; Jan Van Hemelrijck; Bart Meuris
Journal:  J Thorac Cardiovasc Surg       Date:  2011-04-07       Impact factor: 5.209

10.  Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Lung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur J Cardiothorac Surg       Date:  2012-08-25       Impact factor: 4.191

View more
  4 in total

1.  Sutureless aortic valve replacement using a novel autologous tissue heart valve with stent (stent biovalve): proof of concept.

Authors:  Satoru Kishimoto; Yoshiaki Takewa; Yasuhide Nakayama; Kazuma Date; Hirohito Sumikura; Takeshi Moriwaki; Motonobu Nishimura; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2015-01-21       Impact factor: 1.731

Review 2.  Frailty in cardiothoracic surgery: systematic review of the literature.

Authors:  Hiroshi Furukawa; Kazuo Tanemoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-28

3.  ANMCO/SIC/SICI-GISE/SICCH Executive Summary of Consensus Document on Risk Stratification in elderly patients with aortic stenosis before surgery or transcatheter aortic valve replacement.

Authors:  Giovanni Pulignano; Michele Massimo Gulizia; Samuele Baldasseroni; Francesco Bedogni; Giovanni Cioffi; Ciro Indolfi; Francesco Romeo; Adriano Murrone; Francesco Musumeci; Alessandro Parolari; Leonardo Patanè; Paolo Giuseppe Pino; Annalisa Mongiardo; Carmen Spaccarotella; Roberto Di Bartolomeo; Giuseppe Musumeci
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

4.  The number of cardiovascular surgeries in Japan may decrease after 2020.

Authors:  Akihiko Usui; Tomonobu Abe; Yoshimori Araki; Yuji Narita; Masato Mutsuga; Hideki Oshima
Journal:  Nagoya J Med Sci       Date:  2015-08       Impact factor: 1.131

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.